Cargando…

Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells

Thymoquinone (TQ), a bioactive constituent of the volatile oil of Monarda fistulosa and Nigella sativa, possesses cancer-specific growth inhibitory effects, but the underlying molecular mechanisms remain largely elusive. We propose that TQ curbs cancer cell growth through dysfunction of DNA methyltr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Jiuxia, Shen, Na, Yan, Fei, Zhao, Na, Dou, Liping, Wu, Lai-Chu, Seiler, Christopher L., Yu, Li, Yang, Ke, Bachanova, Veronika, Weaver, Eric, Tretyakova, Natalia Y., Liu, Shujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470982/ https://www.ncbi.nlm.nih.gov/pubmed/28415607 http://dx.doi.org/10.18632/oncotarget.16431

Ejemplares similares

Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2021)

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis
por: Yang, Xiaojuan, et al.
Publicado: (2016)

The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)
por: Yan-Fang, Tao, et al.
Publicado: (2013)

Thymoquinone Inhibits Murine Leukemia WEHI-3 Cells In Vivo and In Vitro
por: Ali Salim, Landa Zeenelabdin, et al.
Publicado: (2014)

Correction: Thymoquinone Inhibits Murine Leukemia WEHI-3 Cells In Vivo and In Vitro
Publicado: (2015)

Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients
por: TAO, YAN-FANG, et al.
Publicado: (2014)

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
por: Wu, De-long, et al.
Publicado: (2022)

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia
por: Dou, Liping, et al.
Publicado: (2019)

Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin
por: Han, Yixiang, et al.
Publicado: (2015)

Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
por: Tao, Yan-Fang, et al.
Publicado: (2015)

MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models
por: Fang, Douglas D., et al.
Publicado: (2021)

BCL7A is silenced by hypermethylation to promote acute myeloid leukemia
por: Patiño-Mercau, Juan Rodrigo, et al.
Publicado: (2023)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis
por: Shen, Na, et al.
Publicado: (2014)

Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo
por: Jain, Chetan Kumar, et al.
Publicado: (2015)

Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
por: Gruber, Lisa, et al.
Publicado: (2018)

WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia
por: Kushwaha, Garima, et al.
Publicado: (2016)

Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia
por: Schraw, Jeremy M., et al.
Publicado: (2018)

Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2021)

Prognostic factors for clinical outcomes of patients with central nervous system leukemia
por: Bharucha, Jinai, et al.
Publicado: (2020)

Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
por: Oing, Christoph, et al.
Publicado: (2011)

A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia
por: Hatırnaz Ng, Özden, et al.
Publicado: (2015)

Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
por: Lian, Xiaolan, et al.
Publicado: (2018)

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
por: Le Roy, Aude, et al.
Publicado: (2018)

Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation
por: Tao, Yan-Fang, et al.
Publicado: (2014)

Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia–lymphoma cells
por: Taniguchi, Hiroaki, et al.
Publicado: (2014)

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
por: Lian, Xiaolan, et al.
Publicado: (2018)

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness
por: Yan, Fei, et al.
Publicado: (2017)

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
por: Kim, Daehong, et al.
Publicado: (2021)

RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy
por: Romanova, Ekaterina I., et al.
Publicado: (2022)

Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia
por: Pan, Yunbao, et al.
Publicado: (2017)

Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia
por: Tao, Yan-Fang, et al.
Publicado: (2015)

CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome
por: Li, Mianyang, et al.
Publicado: (2016)

A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia
por: Sun, Jingwen, et al.
Publicado: (2019)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

Is thymoquinone an antioxidant?
por: Staniek, Katrin, et al.
Publicado: (2010)

Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
por: Alhosin, Mahmoud, et al.
Publicado: (2020)

Cellular, Molecular, Pharmacological, and Nano-Formulation Aspects of Thymoquinone—A Potent Natural Antiviral Agent
por: Shoaib, Ambreen, et al.
Publicado: (2023)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
por: Yan, Fei, et al.
Publicado: (2018)

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
por: Guo, Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qc2enilvrmqt0aoircikbakm9c